Primemd Inc. (PRMD) Comparison with companies in other sectors?

Primemd Inc. has a share price of 18.70M. You can analyze Primemd Inc. (PRMD) competitors across different market sectors through stock heatmaps.

What are PRMD's NET and operating margins?

Primemd Inc. (PRMD) operating margin is around 0.40, and net profit margin is approximately 0.30 as of the latest reports.

In what way does PRMD's earnings per share (EPS) trend reflect its financial momentum?

Primemd Inc. (PRMD) EPS is -0.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Primemd Inc. is N/A, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Primemd Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Primemd Inc. like P/E which is 0.002, P/B which is 0.001, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Primemd Inc.

PRMD•PNK

Healthcare

Medical - Care Facilities

$0.00

$0.00(0.00%)

Fundamental Analysis of Primemd Inc. (PRMD)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-0.22

P/E Ratio

ROE

0.73%

Net Margin

0.30%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.61K

Shares OutstandingTotal number of shares issued

$18.70M

Book Value/ShareNet worth per share

$0.40

Revenue/ShareAnnual revenue per share

$0.57

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.22

Net MarginNet income as percentage of revenue

29.90%

Operating MarginOperating income as percentage of revenue

39.60%

ROEReturn on shareholders' equity

73.34%

ROAReturn on total assets

20.49%

ROCEReturn on capital employed

27.98%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

$0.12

Cash/ShareCash and equivalents per share

$0.14

FCF YieldFree cash flow as percentage of market cap

39951.76%

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for PRMDFinancial Ratios Analysis details for PRMD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for PRMDSector Benchmarking details for PRMD are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Primemd Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Primemd Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Primemd Inc.'s unique business strengths and challenges.

Key Financial Metrics for Primemd Inc.

For Primemd Inc., essential financial indicators include EPS -0.22, PE -, and ROE 0.73. These key ratios reveal insights into Primemd Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Primemd Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Primemd Inc.

Metrics like Net Margin 29.90% and ROA 20.49% shed light on how well Primemd Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Primemd Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Primemd Inc.

Using ratios such as P/B Ratio 0.001 and PEG Ratio 0.00, investors can assess whether Primemd Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Primemd Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Primemd Inc.

Financial health indicators, such as Debt/Equity Ratio 0.97 and Cash Flow $0.12, provide a snapshot of Primemd Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Primemd Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Primemd Inc.

Investing in Primemd Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Primemd Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;